Anti-TNF Agents and New Biological Agents (Vedolizumab and Ustekinumab) in the Prevention and Treatment of Postoperative Recurrence After Surgery in Crohn’s Disease-Reference-Cited by-同舟云学术

Anti-TNF Agents and New Biological Agents (Vedolizumab and Ustekinumab) in the Prevention and Treatment of Postoperative Recurrence After Surgery in Crohn’s Disease

Published:2023-07-28 Issue:13 Volume:83 Page:1179-1205
ISSN:0012-6667
Container-title:Drugs
language:en
Short-container-title:Drugs

Author:

Gisbert Javier P.^ORCID,Chaparro María

Funder

Universidad Autónoma de Madrid

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical)

Link

https://link.springer.com/content/pdf/10.1007/s40265-023-01916-2.pdf

Reference176 articles.

1. Tsai L, Ma C, Dulai PS, Prokop LJ, Eisenstein S, Ramamoorthy SL, et al. Contemporary risk of surgery in patients with ulcerative colitis and Crohn's disease: a meta-analysis of population-based cohorts. Clin Gastroenterol Hepatol. 2021;19(10):2031–45 e11.

2. Nos P, Domenech E. Postoperative Crohn’s disease recurrence: a practical approach. World J Gastroenterol. 2008;14(36):5540–8.

3. Yamamoto T. Prevention of recurrence after surgery for Crohn’s disease: efficacy of infliximab. World J Gastroenterol. 2010;16(43):5405–10.

4. Buisson A, Chevaux JB, Bommelaer G, Peyrin-Biroulet L. Diagnosis, prevention and treatment of postoperative Crohn’s disease recurrence. Dig Liver Dis. 2012;44(6):453–60.

5. Buisson A, Chevaux JB, Allen PB, Bommelaer G, Peyrin-Biroulet L. Review article: the natural history of postoperative Crohn’s disease recurrence. Aliment Pharmacol Ther. 2012;35(6):625–33.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preventing Recurrence of Crohn’s Disease Post-Ileocaecal Surgery in Paediatric Patients: A Therapy Guide Based on Systematic Review of the Evidence;Pediatric Drugs;2024-08-31

2. Common Mistakes in Managing Patients with Inflammatory Bowel Disease;Journal of Clinical Medicine;2024-08-14

3. MSCs-exosomes Can Promote Macrophage M2 Polarisation via Exosomal miR-21-5p through Mesenteric Injection: A Promising Way to Attenuate Murine Colitis;Journal of Crohn's and Colitis;2024-07-13

4. Advancements in Targeted Therapies for the Management of Crohn’s Disease: A Comprehensive Review;Cureus;2024-06-05

5. Surgical treatment of inflammatory bowel disease: From the gastroenterologist’s stand-point;World Journal of Gastrointestinal Surgery;2024-05-27